Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Phenylketonuria (PKU)
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Palynziq
Palynziq is indicated for the treatment of patients with phenylketonuria (PKU) aged 16 years and older who have inadequate blood phenylalanine control (blood phenylalanine levels greater than 600 micromol/l) despite prior management with available treatment options.
Phenylketonurias
Pain, Post-operative
Mucopolysaccharidosis IV A
Anemia Associated With End Stage Renal Disease
Hemophilia A With Inhibitor